Clinical manifestations of Kawasaki disease shock syndrome: A case-control study

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 1, 2015, Pages 43-50

  Chen, Pei Shin ^a   Chi, Hsin ^a,b,c   Huang, Fu Yuan ^a   Peng, Chun Chih ^a,b   Chen, Ming Ren ^a,b   Chiu, Nan Chang ^a,b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Children; Kawasaki disease; Kawasaki disease shock syndrome; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; IMMUNOGLOBULIN; VASOACTIVE AGENT;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE DURATION; DRUG MEGADOSE; FEMALE; FLUID RESUSCITATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITALIZED CHILD; HUMAN; HYPOTENSION; IMMUNOTHERAPY; INFANT; KAWASAKI DISEASE SHOCK SYNDROME; LABORATORY TEST; LOW DRUG DOSE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PATIENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEPSIS; SHOCK; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; TREATMENT DURATION; ADOLESCENT; CASE CONTROL STUDY; COMPLICATION; PATHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPOTENSION; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK FACTORS; SEPSIS; SHOCK; TREATMENT OUTCOME;

EID: 84921366522     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.06.005     Document Type: Article

References (40)

1. Mandal S., Pande A., Mandal D., Sarkar A., Kahali D., Panja M. Various coronary artery complications of Kawasaki disease: series of 5 cases and review of literature. J Cardiovasc Dis Res 2012, 3:231-235.
2. Burns J.C., Glodé M.P. Kawasaki syndrome. Lancet 2004, 364:533-544.
3. Lee Y.C., Kuo H.C., Chang J.S., Chang L.Y., Huang L.M., Chen M.R., et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet 2012, 44:522-525.
4. Yanagawa H., Nakamura Y., Yashiro M., Oki I., Hirata S., Zhang T., et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001, 107:e33.
5. Park Y.W., Han J.W., Hong Y.M., Ma J.S., Cha S.H., Kwon T.C., et al. Epidemiological features of Kawasaki disease in Korea, 2006-2008. Pediatr Int 2011, 53:36-39.
6. Chang L.Y., Chang I.S., Lu C.Y., Chiang B.L., Lee C.Y., Chen P.J., et al. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Pediatrics 2004, 114:e678-e682.
7. Huang W.C., Huang L.M., Chang I.S., Chang L.Y., Chiang B.L., Chen P.J., et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 2009, 123:e401-e405.
8. Kuo H.C., Liang C.D., Wang C.L., Yu H.R., Hwang K.P., Yang K.D. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr 2010, 99:1578-1583.
9. Wang C.L., Wu Y.T., Liu C.A., Kuo H.C., Yang K.D. Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 2005, 24:998-1004.
10. Suzuki A., Kamiya T. Visualization of coronary artery lesions in Kawasaki disease by coronary angiography. Cardiol Young 1991, 1:225-233.
11. Kanegaye J.T., Wilder M.S., Molkara D., Frazer J.R., Pancheri J., Tremoulet A.H., et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009, 123:e783-e789.
12. Dominguez S.R., Friedman K., Seewald R., Anderson M.S., Willis L., Glodé M.P. Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics 2008, 122:e786-e790.
13. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease 1984, Research Committee on Kawasaki Disease, Japan: Ministry of Health and Welfare, Tokyo.
14. Matsubara T., Furukawa S., Yabuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 1990, 56:29-36.
15. Lin C.Y., Lin C.C., Hwang B., Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor α among patients with Kawasaki disease. J Pediatr 1992, 121:924-926.
16. Burgner D., Davila S., Breunis W.B., Ng S.B., Li Y., Bonnard C., et al. A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet 2009, 5:e1000319.
17. Kim J.J., Hong Y.M., Sohn S., Jang G.Y., Ha K.S., Yun S.W., et al. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum Genet 2011, 129:487-495.
18. Tsai F.J., Lee Y.C., Chang J.S., Huang L.M., Huang F.Y., Chiu N.C., et al. Identification of novel susceptibility loci for Kawasaki disease in a Han Chinese population by a genome-wide association study. PLoS One 2011, 6:e16853.
19. Khor C.C., Davila S., Breunis W.B., Lee Y.C., Shimizu C., Wright V.J., et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 2011, 43:1241-1246.
20. Davies H.D., Kirk V., Jadavji T., Kotzin B.L. Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr Infect Dis J 1996, 15:1136-1138.
21. Chan L., Chinnock B. Clinicopathological conference: multisystem failure in a child. Acad Emerg Med 2000, 7:169-173.
22. Gatterre P., Oualha M., Dupic L., Iserin F., Bodemer C., Lesaqe F., et al. Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome. Intensive Care Med 2012, 38:872-878.
23. Thabet F., Bafaqih H., Al-Mohaimeed S., Al-Hilali M., Al-Sewairi W., Chehab M. Shock: an unusual presentation of Kawasaki disease. Eur J Pediatr 2011, 170:941-943.
24. Harada T., Ito S., Shiga K., Inaba A., Machida H., Aihara Y., et al. A report of two cases of Kawasaki disease treated with plasma exchange. Ther Apher Dial 2008, 12:176-179.
25. Park S.J., Pai K.S., Kim J.H., Shin J.I. What dose of intravenous immunoglobulin should be administered in Kawasaki disease with suspected systemic capillary leak syndrome? Comment on: shock: an unusual presentation of Kawasaki disease. Eur J Pediatr 2012, 171:203-204.
26. Druey K.M., Greipp P.R. Narrative review: the systemic capillary leak syndrome. Ann Intern Med 2010, 153:90-98.
27. Shin J.I., Lee J.S. Beneficial effect of intravenous immunoglobulins on systemic capillary leak syndrome in patients with monoclonal gammopathy. Crit Care Med 2009, 37:795.
28. Kim M., Kim K. Elevation of cardiac troponin I in the acute stage of Kawasaki disease. Pediatr Cardiol 1999, 20:184-188.
29. Checchia P.A., Borensztajn J., Shulman S.T. Circulating cardiac troponin I levels in Kawasaki disease. Pediatr Cardiol 2001, 22:102-106.
30. Newburger J.W., Sanders S.P., Burns J.C., Parness I.A., Beiser A.S., Colan S.D. Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. Circulation 1989, 79:1237-1246.
31. Imakita M., Sasaki Y., Misugi K., Miyazawa Y., Hyodo Y. Kawasaki disease complicated with mitral insufficiency. Autopsy findings with special reference to valvular lesion. Acta Pathol Jpn 1984, 34:605-616.
32. Printz B.F., Sleeper L.A., Newburger J.W., Minich L.L., Bradley T., Cohen M.S., et al. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol 2011, 57:86-92.
33. Lin Y.J., Lin I.C., Yu H.R., Kuo H.C., Yang K.D., Chang W.C., et al. Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission. Pediatr Cardiol 2013, 34:250-255.
34. Shinohara T., Tanihira Y. A patient with Kawasaki disease showing severe tricuspid regurgitation and left ventricular dysfunction in the acute phase. Pediatr Cardiol 2003, 24:60-63.
35. Wu M.H., Chen H.C., Yeh S.J., Lin M.T., Huang S.C., Huang S.K. Prevalence and the long-term coronary risks of patients with Kawasaki disease in a general population <40 years: a national database study. Circ Cardiovasc Qual Outcomes 2012, 5:566-570.
36. Newburger J.W., Takahashi M., Gerber M.A., Gewitz M.H., Tani L.Y., Burns J.C., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young. Pediatrics 2004, 114:1708-1733.
37. Perrin L., Letierce A., Guitton C., Tran T.A., Lambert V., Koné-Paut I. Comparative study of complete versus incomplete Kawasaki disease in 59 pediatric patients. Joint Bone Spine 2009, 76:481-485.
38. Sudo D., Monobe Y., Yashiro M., Mieno M.N., Uehara R., Tsuchiya K., et al. Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 2012, 171:651-656.
39. Seo J.H., Yu J.J., Ko H.K., Choi H.S., Kim Y.H., Ko J.K. Diagnosis of incomplete Kawasaki disease in infants based on an inflammation at the Bacille Calmette-Guérin inoculation site. Korean Circ J 2012, 42:823-829.
40. Uehara R., Igarashi H., Yashiro M., Nakamura Y., Yanagawa H. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site. Pediatr Infect Dis J 2010, 29:430-433.